PMC:7589163 / 88703-89004 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T390","span":{"begin":89,"end":97},"obj":"Body_part"},{"id":"T391","span":{"begin":208,"end":214},"obj":"Body_part"},{"id":"T392","span":{"begin":215,"end":219},"obj":"Body_part"}],"attributes":[{"id":"A390","pred":"fma_id","subj":"T390","obj":"http://purl.org/sig/ont/fma/fma292381"},{"id":"A391","pred":"fma_id","subj":"T391","obj":"http://purl.org/sig/ont/fma/fma9601"},{"id":"A392","pred":"fma_id","subj":"T392","obj":"http://purl.org/sig/ont/fma/fma62100"}],"text":"Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Atwell et al., 2012 [215] Infants born \u003c33 weeks’ gestationRCT High DHA (∼1%) vs. standard DHA (∼0.3%) in breast milk or formula Not reduced hospitalisation for LRTI problems in the first 18 months."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T181","span":{"begin":208,"end":214},"obj":"Body_part"},{"id":"T182","span":{"begin":215,"end":219},"obj":"Body_part"}],"attributes":[{"id":"A181","pred":"uberon_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"A182","pred":"uberon_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/UBERON_0001913"}],"text":"Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Atwell et al., 2012 [215] Infants born \u003c33 weeks’ gestationRCT High DHA (∼1%) vs. standard DHA (∼0.3%) in breast milk or formula Not reduced hospitalisation for LRTI problems in the first 18 months."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T792","span":{"begin":208,"end":214},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"T793","span":{"begin":291,"end":293},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Atwell et al., 2012 [215] Infants born \u003c33 weeks’ gestationRCT High DHA (∼1%) vs. standard DHA (∼0.3%) in breast milk or formula Not reduced hospitalisation for LRTI problems in the first 18 months."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T72876","span":{"begin":57,"end":77},"obj":"Chemical"},{"id":"T53068","span":{"begin":73,"end":77},"obj":"Chemical"},{"id":"T69889","span":{"begin":170,"end":173},"obj":"Chemical"},{"id":"T99473","span":{"begin":193,"end":196},"obj":"Chemical"}],"attributes":[{"id":"A27608","pred":"chebi_id","subj":"T72876","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A70847","pred":"chebi_id","subj":"T53068","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A72199","pred":"chebi_id","subj":"T69889","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A64791","pred":"chebi_id","subj":"T69889","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A23972","pred":"chebi_id","subj":"T69889","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A98129","pred":"chebi_id","subj":"T69889","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A39077","pred":"chebi_id","subj":"T99473","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A68936","pred":"chebi_id","subj":"T99473","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A73310","pred":"chebi_id","subj":"T99473","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A91670","pred":"chebi_id","subj":"T99473","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"}],"text":"Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Atwell et al., 2012 [215] Infants born \u003c33 weeks’ gestationRCT High DHA (∼1%) vs. standard DHA (∼0.3%) in breast milk or formula Not reduced hospitalisation for LRTI problems in the first 18 months."}

{"project":"LitCovid-sentences","denotations":[{"id":"T586","span":{"begin":0,"end":98},"obj":"Sentence"},{"id":"T587","span":{"begin":100,"end":301},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Atwell et al., 2012 [215] Infants born \u003c33 weeks’ gestationRCT High DHA (∼1%) vs. standard DHA (∼0.3%) in breast milk or formula Not reduced hospitalisation for LRTI problems in the first 18 months."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3575","span":{"begin":31,"end":38},"obj":"Species"},{"id":"3576","span":{"begin":127,"end":134},"obj":"Species"},{"id":"3585","span":{"begin":0,"end":11},"obj":"Species"},{"id":"3605","span":{"begin":57,"end":77},"obj":"Chemical"},{"id":"3606","span":{"begin":170,"end":173},"obj":"Chemical"},{"id":"3607","span":{"begin":193,"end":196},"obj":"Chemical"},{"id":"3637","span":{"begin":208,"end":219},"obj":"Disease"}],"attributes":[{"id":"A3575","pred":"tao:has_database_id","subj":"3575","obj":"Tax:9606"},{"id":"A3576","pred":"tao:has_database_id","subj":"3576","obj":"Tax:9606"},{"id":"A3585","pred":"tao:has_database_id","subj":"3585","obj":"Tax:12814"},{"id":"A3605","pred":"tao:has_database_id","subj":"3605","obj":"MESH:D004281"},{"id":"A3606","pred":"tao:has_database_id","subj":"3606","obj":"MESH:C027493"},{"id":"A3607","pred":"tao:has_database_id","subj":"3607","obj":"MESH:C027493"},{"id":"A3637","pred":"tao:has_database_id","subj":"3637","obj":"MESH:D001943"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Atwell et al., 2012 [215] Infants born \u003c33 weeks’ gestationRCT High DHA (∼1%) vs. standard DHA (∼0.3%) in breast milk or formula Not reduced hospitalisation for LRTI problems in the first 18 months."}